IBN
ICICI Bank Limited
ICICI Bank Limited historical holders
total: 6
Egerton Capital ICICI Bank Limited transactions over time
- Total transactions:
- 13
- New positions:
- 2
- Sold out:
- 2
- Added:
- 3
- Reduced:
- 6
- Held since:
- 2022 Q4
- Held for:
- 10 quarters
- Latest activity:
- 2025 Q2
John Armitage has been an institutional investor in ICICI Bank Limited (IBN) since 2019 Q4. According to 2026 Q2 report, John Armitage doesn't hold any shares. The fund/company first acquired IBN in 2019 Q4, initially purchasing about 14.12M shares. John Armitage later completely sold out the position and reinvested in IBN again in 2022 Q4. Since the initial investment, Egerton Capital has made 12 more transactions in this position.
When did John Armitage exit their IBN position?
John Armitage no longer holds ICICI Bank Limited (IBN). They sold off their entire position in 2025 Q2, closing out an investment that began in 2019 Q4.
When did John Armitage first invest in IBN?
John Armitage first invested in ICICI Bank Limited (IBN) in 2019 Q4 at the reported quarter-end price of $15.09 per share, acquiring 14,119,109 shares in their initial purchase.
What is John Armitage's average cost basis for IBN?
Based on historical transaction data, John Armitage's estimated cost basis for ICICI Bank Limited (IBN) is approximately $23.48 per share. This represents their average reported price* across all buy transactions.
Has John Armitage reinvested in IBN after selling?
Yes, John Armitage has shown renewed interest in ICICI Bank Limited (IBN). After completely selling their position, they reinitiated an investment in 2022 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $23.48
- Weighted AVG sell price:
- $27.87
IBN transactions history by Egerton Capital
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q2
|
0.00%
|
0
|
$31.52
|
|
-100% (-5,031,304)
|
-1.83%
|
|
2025 Q1
|
1.83%
|
5,031,304
|
$31.52
|
$158,586,702
|
-21.21% (-1,354,572)
|
-0.49%
|
|
2024 Q4
|
2.21%
|
6,385,876
|
$29.86
|
$190,682,257
|
+61.11% (+2,422,251)
|
+0.84%
|
|
2024 Q3
|
1.19%
|
3,963,625
|
$29.85
|
$118,314,206
|
-28.47% (-1,577,354)
|
-0.48%
|
|
2024 Q2
|
1.61%
|
5,540,979
|
$28.81
|
$159,635,605
|
-8.62% (-522,571)
|
-0.15%
|
|
2024 Q1
|
1.55%
|
6,063,550
|
$26.41
|
$160,138,356
|
-50.78% (-6,256,660)
|
-1.79%
|
|
2023 Q4
|
3.18%
|
12,320,210
|
$23.84
|
$293,713,806
|
+44.21% (+3,776,723)
|
+0.98%
|
|
2023 Q3
|
2.29%
|
8,543,487
|
$23.12
|
$197,525,419
|
-3.88% (-345,018)
|
-0.08%
|
|
2023 Q2
|
2.12%
|
8,888,505
|
$23.08
|
$205,146,695
|
+16.27% (+1,243,632)
|
+0.3%
|
|
2023 Q1
|
1.78%
|
7,644,873
|
$21.58
|
$164,976,359
|
-25.16% (-2,570,107)
|
-0.48%
|
|
2022 Q4
|
1.92%
|
$21.89
|
new
|
|||
|
2020 Q1
|
0.00%
|
$15.09
|
-100% (-14,119,109)
|
|||
|
2019 Q4
|
1.53%
|
$15.09
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.